2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
This guideline cites 2 of the 199 landmark trials in our Cardiology register.
- Issued by
- ACC/
AHA - Year
- 2015
- Source
- Page RL, Joglar JA, et al. Circulation. 2016;133(14):e506–e574.doi 10.1161/CIR.0000000000000311
The US SVT guideline predates the ESC's by four years and the two are largely concordant: vagal manoeuvres and adenosine first for acute termination, catheter ablation as definitive therapy for symptomatic AVNRT and AVRT, and electrophysiological risk stratification rather than reflex ablation in asymptomatic pre-excitation. Randomised evidence in this field is unusually thin, so the recommendations lean heavily on registries and small crossover studies — the three register trials below carry a disproportionate share. Where the documents differ it is mostly a matter of vintage: the modified Valsalva manoeuvre (REVERT) landed in the same year as this guideline and only reached full guideline status with the ESC in 2019, which is also more assertive about ablating high-risk asymptomatic pre-excitation.
Pre-excitation & accessory-pathway ablation1
- 2003Pappone WPWCardiology · Arrhythmia · Pre-excitationIn 72 asymptomatic patients with a Wolff-Parkinson-White pattern judged high-risk on electrophysiological testing, prophylactic radiofrequency ablation of the accessory pathway markedly reduced arrhythmic events over 5 years compared with no treatment.RR 0.0895% CI 0.02-0.33Read →
Inappropriate sinus tachycardia1
- 2012Cappato ISTCardiology · Arrhythmia · Inappropriate sinus tachycardiaIn 21 patients with symptomatic inappropriate sinus tachycardia, ivabradine eliminated most symptoms and lowered heart rate at rest, on standing and during exertion compared with placebo.RR 0.2595% CI 0.18-0.34Read →
Cited landmark trials not yet in the register3
Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.
- 2004Flecainide/propafenone pill-in-the-pocket
Self-administered antiarrhythmic conversion for infrequent, well-tolerated episodes.
- 2010CYRANO
Cryoablation vs. radiofrequency ablation for AVNRT.
- 2009Adenosine vs. verapamil trials
Comparable termination rates; adenosine is faster, verapamil longer-acting.
Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.